REPROGO LIMITED

Company number NI668614 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£40,216

Balance sheet as at 2025-03-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2020-03-24
Employees
1 (2025 accounts)
Registered office
C/O Qubis, 63 University Road, Belfast, Northern Ireland, BT7 1NF
Postcode
BT7 1NF
Capital
98 GBP
Accounts category
Micro

Accounts

Last made up to
2025-03-31
Next due by
2026-12-31
Financial year end
31 March

Confirmation statement

Last statement dated
2026-02-23
Next due by
2027-03-09
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 2 current · 2 resigned

Sophia KELAINI Director
Appointed 2021-07-05
Appointed 2021-07-05

View all officers and resignations →

Group structure

Controlled by QUBIS LIMITED — since 2020-03-24

From persons-with-significant-control filings on the public register.

Contact details

Website
reprogo.org

Here in ReproGO, we are world leaders in vascular stem cell biology. Your one stop solution for matched patient-specific cells.

Among its peers

29

companies are registered at this postcode →

No.13 of the largest research and experimental development on biotechnology companies in Belfast →

Competitors Belfast

This company ranks 13 among research and experimental development on biotechnology in Belfast.

Full league table →

The class of 2020

41%

of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →